Miranda Toledano
Chief Executive Officer bei ENTERA BIO LTD.
Vermögen: 453 840 $ am 31.03.2024
Aktive Positionen von Miranda Toledano
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ENTERA BIO LTD. | Director/Board Member | 27.09.2018 | - |
| Chief Executive Officer | 15.07.2022 | - | |
| Director of Finance/CFO | 16.05.2022 | 15.07.2022 | |
| Independent Dir/Board Member | 27.09.2018 | 16.05.2022 | |
| JOURNEY MEDICAL CORPORATION | Director/Board Member | 01.05.2021 | - |
| Independent Dir/Board Member | 01.05.2021 | - | |
Lipomedix Pharmaceuticals Ltd.
 Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Director/Board Member | 05.08.2019 | - |
Karriereverlauf von Miranda Toledano
Ehemalige bekannte Positionen von Miranda Toledano
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| NEXGEL, INC. | Director/Board Member | 09.09.2021 | 31.03.2024 |
| Independent Dir/Board Member | 09.09.2021 | 31.03.2024 | |
| COMPASS THERAPEUTICS, INC. | Director/Board Member | 25.06.2021 | 24.05.2022 |
| Independent Dir/Board Member | 25.06.2021 | 24.05.2022 | |
TRIGR Therapeutics, Inc.
 TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Director/Board Member | 01.01.2018 | 01.06.2021 |
| Chief Operating Officer | 01.01.2018 | 01.06.2021 | |
| Director of Finance/CFO | 01.01.2018 | 01.06.2021 | |
| SORRENTO THERAPEUTICS, INC. | Corporate Officer/Principal | 13.09.2016 | 01.08.2017 |
MLV & Co. LLC
 MLV & Co. LLC Investment Banks/BrokersFinance Founded in 2010, MLV & Co. LLC is a broker/dealer located in New York City. The firm is a direct subsidiary of FBR Capital Markets Holdings, Inc. and their ultimate parent is FBR & Co. (NASDAQ: FBRC), which acquired the firm in 2015. Their research focuses on small to mid-sized companies with disruptive technologies that have the potential to drive significant market changes. MLV & Co.'s coverage universe includes the life sciences, oil & gas and metals & mining sectors. | Corporate Officer/Principal | 01.01.2012 | 01.09.2016 |
| ROYALTY PHARMA PLC | Chief Investment Officer | 01.01.2004 | 01.01.2010 |
| ░░░░░ ░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░ ░░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Miranda Toledano
| Tufts University | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 10 |
| Israel | 4 |
| 2 |
Operativ
| Director/Board Member | 6 |
| Corporate Officer/Principal | 4 |
| Independent Dir/Board Member | 4 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 3 |
| Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| ENTERA BIO LTD. | Health Technology |
| JOURNEY MEDICAL CORPORATION | Health Technology |
| ROYALTY PHARMA PLC | Health Technology |
| COMPASS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Ernst & Young (Israel) Ltd.
 Ernst & Young (Israel) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young (Israel) Ltd. is an Israeli company that provides accounting services. The private company is based in Tel Aviv, Israel. | Commercial Services |
RP Management LLC
 RP Management LLC Miscellaneous Commercial ServicesCommercial Services RP Management LLC provides pharmaceutical royalty liquidity services. It provides liquidity to holders of interests in revenue-producing intellectual property in biopharmaceutical products and finances the clinical development of biopharmaceutical products in exchange for a royalty interest. The firm serves research institutions, inventors, and biotechnology and pharmaceutical companies. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY. | Commercial Services |
| NexGel, Inc. | |
Lipomedix Pharmaceuticals Ltd.
Lipomedix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Lipomedix Pharmaceuticals Ltd. engages in the development of cancer therapy based on liposome delivery. It offers Promitil®, a proprietary formulation of a lipid-based pro-drug of MMC (MLP) which enables efficient delivery and release of active MMC to tumors in vivo. The company was founded by Alberto Gabizon and Rami Kremien and is headquartered in Jerusalem, Israel. | Health Technology |
TRIGR Therapeutics, Inc.
TRIGR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trigr Therapeutics, Inc. engages in pharmaceuticals industry group. The company is headquartered in Irvine, CA. | Health Technology |
MLV & Co. LLC
MLV & Co. LLC Investment Banks/BrokersFinance Founded in 2010, MLV & Co. LLC is a broker/dealer located in New York City. The firm is a direct subsidiary of FBR Capital Markets Holdings, Inc. and their ultimate parent is FBR & Co. (NASDAQ: FBRC), which acquired the firm in 2015. Their research focuses on small to mid-sized companies with disruptive technologies that have the potential to drive significant market changes. MLV & Co.'s coverage universe includes the life sciences, oil & gas and metals & mining sectors. | Finance |
- Börse
- Insiders
- Miranda Toledano
- Erfahrung
